Peer-to-peer engagement

What is peer-to-peer engagement?

Peer-to-peer engagement is interaction between medical professionals that supports scientific education, evidence sharing and clinical discussion. It can take place at congresses, in an advisory board, during a roundtable or in a one-to-one meeting. Formats may be face to face, virtual or hybrid.

The exchange is typically non-promotional and centred on evidence, clinical experience, unmet need or patient care. A pharmaceutical company may facilitate the interaction, select an appropriate format or provide scientific materials, but the discussion should retain credible medical independence and comply with applicable governance requirements.

Why does peer-to-peer engagement matter in medical affairs?

For medical affairs teams, peer interaction can make complex evidence more relevant to clinical practice. Clinicians can question data, compare experience and explore where findings do or do not apply to particular patient populations. This supports informed understanding and can build confidence in appropriate evidence-based practice.

It also gives teams a clearer view of knowledge gaps, evidence needs and differences in clinical practice. When captured appropriately, these observations can inform medical strategy, education, evidence generation and future communications. Engagement should not be used to direct prescribing or disguise a promotional objective.

How is peer-to-peer engagement planned and run in practice?

The team starts by defining a specific scientific purpose and the audience that needs to take part. It then chooses a format suited to that purpose, rather than treating a meeting or speaker activity as the objective itself.

A typical process covers:

• Defining the clinical question, learning need or evidence gap.
• Selecting participants for relevant expertise, experience and audience fit.
• Briefing chairs, faculty or facilitators on the scientific scope and their roles.
• Preparing accurate, balanced and approved evidence materials.
• Allowing enough time for questions, challenge and discussion between participants.
• Managing contracts, transfers of value, consent, privacy and local compliance requirements.
• Recording agreed outputs and routing valid observations into medical insight capture.

Good facilitation keeps the exchange focused without scripting participants' views. Medical, compliance and operational responsibilities should be clear before the activity begins.

How should peer-to-peer engagement be measured?

Measurement should reflect the purpose of the engagement. Attendance and participation show reach, but they do not establish scientific value on their own. Teams may assess the relevance of questions, depth of discussion, changes in understanding, identified evidence gaps, participant feedback and whether agreed follow-up actions were completed.

Measures should be set before the activity and interpreted alongside qualitative evidence. Direct attribution to prescribing is generally unsuitable for non-promotional medical engagement. Insight volume should also be treated cautiously: repeated, specific and actionable observations are usually more useful than a large collection of unstructured comments.

Where do teams commonly go wrong?

Common problems include selecting familiar speakers rather than the right peers, using content that leaves little room for discussion, mixing medical and promotional objectives, and counting interactions without assessing their quality. Another failure is to collect observations without documenting context, checking whether they are genuinely new or assigning follow-up ownership.

Credibility also suffers when company involvement is unclear or when faculty appear overly directed. Good practice requires transparent roles, balanced evidence, fair-market-value arrangements where applicable, and a clear separation between legitimate scientific discussion and product promotion.

How does peer-to-peer engagement differ from scientific exchange and advisory work?

Peer-to-peer engagement describes who is interacting and the professional basis of the discussion. Scientific exchange is the broader sharing and discussion of scientific or clinical information; it may occur between a company medical representative and an individual healthcare professional as well as between external peers.

Advisory work is narrower and is designed to obtain defined advice from selected experts for a legitimate business or scientific need. Peer-to-peer engagement may occur within an advisory board, congress session or roundtable, but not every peer interaction is advisory. It sits alongside medical education, field medical engagement and insight generation rather than replacing them.